Analysis | The Technology 202: Big Tech went big on lobbying spending – and privacy advocates are concerned

United States News News

Analysis | The Technology 202: Big Tech went big on lobbying spending – and privacy advocates are concerned
United States Latest News,United States Headlines
  • 📰 washingtonpost
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 72%

Analysis: Big Tech went big on lobbying spending in Washington – and privacy advocates are concerned

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

washingtonpost /  🏆 95. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Analysis | The Technology 202: Apple's Tim Cook wants Congress to rein in data brokersAnalysis | The Technology 202: Apple's Tim Cook wants Congress to rein in data brokersAnalysis: Apple's Tim Cook wants Congress to rein in data brokers
Read more »

Nancy Pelosi's very big accusation against the White HouseNancy Pelosi's very big accusation against the White HouseSpeaker Nancy Pelosi canceled a planned trip to visit troops in Afghanistan Friday, after -- her office alleged in a statement -- the White House leaked the details of the congressional delegation's commercial plane travel.
Read more »

Defense and tech stocks are the big winners of Trump's first 2 years in officeDefense and tech stocks are the big winners of Trump's first 2 years in officeIt's been two years since Donald Trump was inaugurated as president of the United States. In that time, defense and tech stocks, have blown everybody out of the water.
Read more »

Facebook is the most 'vulnerable' big tech firm facing disruption, top VC saysFacebook is the most 'vulnerable' big tech firm facing disruption, top VC saysThe privacy scandals that have hit Facebook have made it the most 'vulnerable' large technology firm when it comes to the potential to be disrupted, a top VC told CNBC at Davos.
Read more »

A Big, Fatty Opportunity for Big PharmaA Big, Fatty Opportunity for Big PharmaThe next multibillion-dollar therapeutic area for drug companies may be fatty liver disease, but there are a few practical hurdles to overcome first.
Read more »



Render Time: 2025-02-26 14:36:03